EndoChoice Holdings Inc(NYSE:GI) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Aug 3, 2016. Company reported revenue of $19.25M. Analysts estimated a revenue of $20.67M. Earnings per share were $-0.48. Analysts had estimated an EPS of $-0.52.
In a different note, JP Morgan said it Initiates Coverage on EndoChoice Holdings Inc, according to a research note issued on Jul 13, 2016. The shares have been rated ‘Overweight’ by the firm.
EndoChoice Holdings Inc (GI) shares turned negative on Fridays trading session with the shares closing down -0.06 points or -1.50% at a volume of 36,209. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $4. The peak price level was also seen at $4 while the days lowest was $3.9. Finally the shares closed at $3.94. The 52-week high of the shares is $17.15 while the 52-week low is $3.64. According to the latest information available, the market cap of the company is $103 M.
Several Insider Transactions has been reported to the SEC. On Mar 16, 2016, Mark Gilreath (CEO) purchased 20,000 shares at $5.06 per share price.Also, On Mar 14, 2016, David L Kaufman (director) purchased 89,450 shares at $4.81 per share price.On Mar 11, 2016, J Scott Carter (director) purchased 49,995 shares at $4.66 per share price, according to the Form-4 filing with the securities and exchange commission.
ECPM Holdings LLC is a medical device company. The Company is focused on designing and commercializing a platform of products for gastrointestinal (GI) caregivers. It offers a range of products and services that span single-use devices and infection control products pathology and imaging systems. The Company’s Fuse system an endoscopy system used for visualization of the GI tract and related therapeutic interventions enables a wider field of view for upper and lower endoscopy procedures. The Fuse colonoscope offers a 330? view of the colon during colonoscopy instead of the 140? to 170? view offered by standard colonoscopes. Its CinchPad is used to improve the transport process of endoscopes after use. The Company’s products are used in colonoscopy and esophagogastroduodenoscopy (EGD) and other procedures of the upper GI tract. The Company serves over 2500 GI departments that perform endoscopic procedures.